Zacks Research Cuts Earnings Estimates for Tenet Healthcare

Tenet Healthcare Corporation (NYSE:THC) – Analysts at Zacks Research dropped their Q2 2027 EPS estimates for shares of Tenet Healthcare in a report issued on Thursday, May 14th. Zacks Research analyst Team now anticipates that the company will post earnings of $4.17 per share for the quarter, down from their previous estimate of $4.75. The consensus estimate for Tenet Healthcare’s current full-year earnings is $17.64 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q3 2027 earnings at $4.06 EPS, Q4 2027 earnings at $4.62 EPS and FY2027 earnings at $17.17 EPS.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. The firm had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm posted $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS.

Several other research analysts have also weighed in on the company. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Tenet Healthcare in a research report on Friday, March 27th. Wall Street Zen cut shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 11th. Leerink Partners boosted their target price on shares of Tenet Healthcare from $255.00 to $264.00 and gave the stock an “outperform” rating in a report on Friday, February 20th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Finally, Mizuho boosted their price objective on shares of Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a research note on Thursday, March 12th. Nineteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $244.16.

Tenet Healthcare Stock Performance

THC opened at $192.50 on Tuesday. The business’s 50-day simple moving average is $198.47 and its 200 day simple moving average is $203.57. Tenet Healthcare has a 52-week low of $146.60 and a 52-week high of $247.21. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The firm has a market capitalization of $16.58 billion, a PE ratio of 10.01, a PEG ratio of 1.30 and a beta of 1.30.

Insider Buying and Selling at Tenet Healthcare

In other news, EVP Paola M. Arbour sold 6,500 shares of the company’s stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the transaction, the executive vice president owned 29,291 shares of the company’s stock, valued at approximately $6,983,853.13. This represents a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The disclosure for this sale is available in the SEC filing. Insiders sold 46,517 shares of company stock valued at $10,943,111 in the last quarter. 0.97% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. Triumph Capital Management acquired a new stake in Tenet Healthcare during the third quarter worth approximately $25,000. Activest Wealth Management bought a new position in Tenet Healthcare during the 4th quarter worth $26,000. Elyxium Wealth LLC bought a new stake in shares of Tenet Healthcare during the 4th quarter valued at $29,000. William B. Walkup & Associates Inc. bought a new position in shares of Tenet Healthcare in the third quarter worth $32,000. Finally, Canada Pension Plan Investment Board acquired a new position in Tenet Healthcare in the second quarter valued at about $35,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.